Clinical trials: Vestibular Function
Vestibular Function Tests, Dizziness
Efficacy of a Transcranial Vibrating System for Minimizing Dizziness During Caloric Testing
Vestibular disorders are among the most common causes of disability in society. Vestibular dysfunction affects over one third of the population over the age of 40 and a significant percentage of the younger population.
- Trial name
- NCT03618199
- Testing
- Efficacy of transcranial vibrating system on mitigating dizziness and nausea during caloric testing
- Where
- United States
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- Otolith Labs
Vestibular Function Tests
Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical)
The purpose of this research study is to test whether a Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical) is able to reliably evaluate the vertical semicircular canals in patients with vestibular dysfunctions.
- Trial name
- NCT04087044
- Testing
- Computerized Rotational Head Impulse Test ( crHIT)-Vertical
- Where
- 3 sites in United States
- Volunteers
- 186 people, healthy volunteers welcome
- Sponsor
- Neurolign
Acquired Brain Injury
VR-based Remote Rehabilitation for Pediatric ABI
The primary objective of this study is to evaluate the feasibility and effectiveness of an at-home program of VR-based vestibular and oculomotor rehabilitation on improving postural stability, ocular motility and activities of…
- Trial name
- NCT05052905
- Testing
- LibraVR
- Where
- Israel
- Volunteers
- 2 people
- Sponsor
- Libra At Home LTD
Normal Elderly Population
Relationship Between Vestibular Function and Topographic Memory
The purpose of this study is to evaluate visual and nonvisual topographic memory impairment and its relationship to vestibular function in humans.
- Trial name
- NCT01780896
- Where
- 2 sites in United States
- Volunteers
- 50 people
- Sponsor
- Biomedical Development Corporation
Vertigo, Autonomic Dysfunction
Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo
This study aims to evaluate the efficacy and safety of Vespireit, prolonged-release tablets, 15 mg (Valenta Pharm JSC, Russia) in comparison with Arlevert, tablets, 40 mg + 20 mg (Menarini International Operations Luxembourg…
- Trial name
- NCT06321341
- Testing
- Vespireit, Arlevert
- Where
- 4 sites in Russia
- Volunteers
- 160 people
- Sponsor
- Valenta Pharm JSC